239 related articles for article (PubMed ID: 30728365)
21. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
[TBL] [Abstract][Full Text] [Related]
22. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1.
Luo J; Chen P; Xie W; Wu F
Oncol Rep; 2017 Aug; 38(2):1067-1074. PubMed ID: 28677784
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
25. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.
Xie X; Xu X; Sun C; Yu Z
Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.
Yuan X; Wen Y; Shi Q; Zhao Y; Ding J
Biochem Biophys Res Commun; 2024 Feb; 695():149424. PubMed ID: 38169186
[TBL] [Abstract][Full Text] [Related]
27. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells.
Gailhouste L; Gomez-Santos L; Hagiwara K; Hatada I; Kitagawa N; Kawaharada K; Thirion M; Kosaka N; Takahashi RU; Shibata T; Miyajima A; Ochiya T
Hepatology; 2013 Sep; 58(3):1153-65. PubMed ID: 23532995
[TBL] [Abstract][Full Text] [Related]
28. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
29. miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma.
Liu J; Su Z; Zeng Y; Zhang H; Yang S; Liu G
Oncol Rep; 2017 Mar; 37(3):1445-1450. PubMed ID: 28184924
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
[TBL] [Abstract][Full Text] [Related]
31. miR-365 regulates liver cancer stem cells via RAC1 pathway.
Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT
Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377
[TBL] [Abstract][Full Text] [Related]
32. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124.
Zhang S; Liu Y; Liu Z; Zhang Y; Chen G; Li K; Tang K
J BUON; 2019; 24(6):2402-2410. PubMed ID: 31983112
[TBL] [Abstract][Full Text] [Related]
33. Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression.
Wang B; Chen H; Zhang C; Yang T; Zhao Q; Yan Y; Zhang Y; Xu F
Cancer Biother Radiopharm; 2018 Jun; 33(5):194-202. PubMed ID: 29916745
[TBL] [Abstract][Full Text] [Related]
34. Identification of the prognostic, diagnostic, and biological significance of the miR-148a-3p/cathepsin A axis in hepatocellular carcinoma.
Zhao X; Chai W; Wang T; Chen X; Zhang L; Li F; Liu R
J Biochem Mol Toxicol; 2022 Dec; 36(12):e23208. PubMed ID: 36065643
[TBL] [Abstract][Full Text] [Related]
35. The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare.
Deng P; Li M; Wu Y
J Healthc Eng; 2022; 2022():5914541. PubMed ID: 35028121
[TBL] [Abstract][Full Text] [Related]
36. MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.
Lai YY; Shen F; Cai WS; Chen JW; Feng JH; Cao J; Xiao HQ; Zhu GH; Xu B
Tumour Biol; 2016 Oct; 37(10):14165-14171. PubMed ID: 27542674
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
39. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
[TBL] [Abstract][Full Text] [Related]
40. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]